Breaking News
Get 45% Off 0
🧩 Based on my current watchlist, how should I diversify my portfolio?
Ask WarrenAI

Brenda O'Farrell

  • Analysis & Opinion

Brenda O'Farrell's Opinion & Analysis
A complete archive of Brenda O'Farrell's articles, including current analysis & opinion - Page 7

One of the best known analysts covering marijuana stocks is Vivien Azer, a managing director with Cowen. She has been watching the cannabis industry since 2016, which is before legalization in Canada....
With today being Apr. 20, or, as the marijuana industry likes to refer it, 4/20, the annual celebration of all things pot-related, added attention will be focused on the cannabis sector.The overall...
Canadian cannabis stocks are being given some of the credit for propelling the Toronto Stock Exchange, the country’s main stock index, to posting an impressive gain in the first quarter of...
Just like Christmas, which everyone knows is coming, the lack of surprise does not diminish its ability to be a big event. That is the effect that last weekend's deal by New York state legislators to...
Shares of Hexo Corp (NYSE:HEXO) (TSX:HEXO) continued to trade down early this week after the cannabis grower unveiled its latest earnings result last week that showed an almost $21-million loss on...
While much of the focus in the cannabis sector is currently centered on players positioning themselves in anticipation of US expansion, a small Canadian marijuana company, Organigram Holdings, just...
Many observers of the cannabis sector thought that 2021 was off to a roaring start, with the shares of a number of leading companies posting double-digit gains on the prospect of national legalization...
Shares of Cronos Group (NASDAQ:CRON) (TSX:CRON) bounced back yesterday, regaining some of what they lost at the end of last week when the Canadian-based cannabis grower reported its fourth-quarter...
Tilray (NASDAQ:TLRY) grabbed all the headlines last week after it posted its first profitable quarter—on an adjusted basis —last Wednesday. But by the end of the week, it was Aphria...
The latest deal creating a buzz in the cannabis industry is the US$7.2-billion takeover of GW Pharma (NASDAQ:GWPH) by a little-known, Ireland-based company—Jazz Pharmaceuticals (NASDAQ:JAZZ).The...